Skip to content
Forskning· NewsAvailable

Google DeepMind Maps 9 Billion DNA Variants in AlphaGenome Atlas

Google DeepMind has launched AlphaGenome Atlas, a platform featuring predictions for 9 billion DNA variants intended to help researchers understand genetic diseases.

By the Aheadline editorial team·9 sep. 2026·2 min read·Source: Entity-watch: Google DeepMindVerifierad signalAI-generated
Google DeepMind Maps 9 Billion DNA Variants in AlphaGenome Atlas
Google DeepMind Maps 9 Billion DNA Variants in AlphaGenome Atlas
Google DeepMind Maps 9 Billion DNA Variants in AlphaGenome Atlas
By · Policy- & EU-reporter

What happened?

Google DeepMind has unveiled AlphaGenome Atlas, a database and platform containing predictions for the effects of 9 billion single-nucleotide variants in the human genome. The platform covers every conceivable change to a single DNA letter and is provided free of charge for academic research via a web portal. The findings were officially presented by DeepMind’s research team on September 8, 2026.

Key facts

Antal förutsagda DNA-varianter9 miljarder
Lanseringsdatum8 september 2026
TillgänglighetGratis för akademisk forskning

Today, we are introducing AlphaGenome Atlas: a platform containing predictions for the effects of 9 billion single-nucleotide variants — every single-letter change possible — in the human genome.

AlphaGenome Atlas team, Forskarteam hos Google DeepMind · Google DeepMind

Why it matters

Understanding how individual genetic variations influence biology and disease development has long been one of genomics' greatest challenges. By using AI to model the effects of all 9 billion potential point mutations in advance, researchers can reduce the time required for experimental analyses and accelerate the development of targeted treatments and diagnostics.

Who is affected?

The initiative is primarily aimed at academic researchers, geneticists, biomedical scientists, and drug developers worldwide. By offering a searchable atlas of mutations, research groups can more quickly identify which genetic abnormalities contribute to diseases.

Impact on the EU

The platform is available globally and free for academic research via a web portal. EU-based researchers and institutions thus have full access to the tool under current data protection regulations and EU policies for open science.

What else you should know

DeepMind emphasises that the dataset is one of the most comprehensive mappings of the effects of genetic mutations on molecular biology ever created. The tool is expected to become an important resource in functional genomics and precision medicine.

Frequently asked questions

Quick answers about this story

Vad har hänt?
Google DeepMind har lanserat AlphaGenome Atlas, en plattform med AI-baserade förutsägelser för effekterna av 9 miljarder enkelnukleotidvarianter i det mänskliga genomet.
När hände det?
Google DeepMind publicerade nyheten om AlphaGenome Atlas den 8 september 2026.
Varför spelar det roll?
Kartläggningen gör det möjligt för forskare att snabbt förstå hur enskilda mutationer påverkar molekylärbiologin, vilket kan påskynda biologisk forskning och utveckling av sjukdomsbehandlingar.
Är AlphaGenome Atlas tillgänglig i Sverige och EU?
Ja, plattformen är gratis och tillgänglig via en webbportal för akademisk forskning över hela världen, inklusive i EU och Sverige.
Original source
Entity-watch: Google DeepMind·deepmind.google

The link opens in a new window and leads to the publisher's own site.

Verifierad signal

Källan har spårats automatiskt från utgivaren via Aheadlines signalkedja.

AI-verktyg i artikeln

Topics

#Google DeepMind#Machine Learning
[ STAY UP TO DATE ]

Get similar news straight to your inbox

No affiliate linksCancel anytimeGDPR-friendly
[ Frequency ]
[ What do you want to read about? ]

You'll receive updates on 2 topics.

The reader's room

Send in a question or an addition. The newsroom reads everything before it's published and replies when relevant. No AI-generated text – just people.

Sign in to submit a comment or question.

Loading comments…
How this affects you

Read the article through your role

  • Decide whether this affects strategy over 6–12 months or is just noise.
  • Discuss with leadership: do we own the right question or does ownership need to move?
  • Ask: what risk are we taking by NOT acting on this this quarter?

Generated angle — not editorial analysis of "Google DeepMind Maps 9 Billion DNA Variants in AlphaGenome A"